New Rx for Myeloid Malignancies Moves to Phase II Clinical Trials
Phase I trial involving 47 patients identified maximum tolerated dose of 400 mg once daily
Similar Adverse Effects Seen for St. John’s Wort, Fluoxetine
Majority reported concern females, 26 to 50 years of age
Patients Report Improved Care Access, Better Health With ACA
Gains seen in how many adults have insurance and a doctor, and say they are in better health
Atorvastatin/Ezetimibe Beats Atorvastatin After PCI
Combination therapy linked to greater coronary plaque regression in Japanese patients
ASCO Calls for Cancer Trials to Include More Seniors
Older adults react differently to treatment, oncology group notes
Beetroot Juice Supplementation May Help Lengthen Workouts
Reduction in systolic, diastolic BP, total peripheral resistance at rest and during exercise
FDA Approves Praluent for Certain Cases of High Cholesterol
First in a new class of injectable cholesterol-lowering medications
Delays Noted in the Reporting of Serious Patient Harms to FDA
Analysis found roughly 10 percent of cases were filed after 15-day deadline passed
Human Breast Milk Effective for Atopic Dermatitis in Infants
No significant difference in outcomes for human breast milk, 1 percent hydrocortisone ointment
Review: Eradicating H. pylori Cuts Incidence of Gastric Cancer
Reduction in the incidence of gastric cancer with tx of asymptomatic, otherwise healthy individuals
